The test will be developed by using Chembio’s patented Dual Path Platform (DPP) technology together with proprietary reagents developed by Cornell University and the Oswaldo Cruz Foundation at
Cell Therapeutics (CTI) has completed the submission of New Drug Application (NDA) to the FDA for pixantrone. It is intended to treat relapsed or refractory, aggressive non-Hodgkin’ lymphoma
Atox Bio and Fast-Track Drugs & Biologics have signed R&D collaboration agreement for the development of Atox Bio’s novel mechanism-based immunomodulator peptide, AB103. It is intended for the
Oculus Innovative Sciences (Oculus) has confirmed the effectiveness of Microcyn Technology at inactivating the H1NI Swine Influenza A. A virucidal time-kill suspension test conducted by BioScience Laboratories showed
TriLink has signed a sales and license agreement with Glen Research to sell TriLink’s CleanAmp Amidites. Glen Research can now sell the patented CleanAmp Amidites to third parties
Takeda has completed the acquisition of IDM Pharma for $2.64 per share in cash, through a short-form merger of Jade, a wholly-owned subsidiary of Takeda, into IDM. With
Neuralstem has entered into a sponsored research agreement with the China Medical University & Hospital of Taiwan, to prepare for a human clinical trial (using Neuralstem’s human spinal
Living Cell Technologies (LCT) has announced that New Zealand Ministery of Health has authorized LCT’ New Zealand phase I/IIa clinical trial of Diabecell, for insulin dependent diabetes. The
CEL-SCI has filed a provisional US patent application covering its LEAPS immune therapy drugs (vaccines). It is intended for the prevention/treatment of H1N1, swine flu, bird flu, Influenza
Matrixx has said that it is in the process of formally notifying retailers, wholesalers and distributors nationwide, of its recall of all Zicam Cold Remedy Nasal Gel and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.